Drug interactions with mefloquine oral and tipranavir oral

mefloquine oral brand names and other generic formulations include:

Lariam Oral

All generic drug interactions for mefloquine oral (lists will include brand and generic names):

tipranavir oral brand names and other generic formulations include:

No brand names available

All generic drug interactions for tipranavir oral (lists will include brand and generic names):
Serious - Use AlternativePotential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed

mefloquine oral and tipranavir oral

mefloquine oral increases levels of tipranavir oral by altering drug metabolism. Levels of mefloquine may increase leading to increased side effects. Avoid combining these drugs and for 15 weeks after stopping mefloquine.

Patient Drug Interactions Source: RxList
© 2014 RxList, Inc.
Serious - Use AlternativePossible serious or life-threatening interaction. Monitor closely. Use alternatives if available.

mefloquine oral and tipranavir oral

mefloquine oral increases levels of tipranavir oral by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use alternatives if available. Potential for increased toxicity. Avoid coadministration during and for 15 weeks after discontinuing mefloquine.

Clinical Drug Interactions Source: Medscape from WebMD
© 1994-2014 WebMD, LLC.
Serious - Use AlternativePotential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed

tipranavir oral and mefloquine oral

tipranavir oral increases levels of mefloquine oral by altering drug metabolism. Levels of mefloquine may increase leading to increased side effects. Avoid combining these drugs and for 15 weeks after stopping mefloquine.

Patient Drug Interactions Source: RxList
© 2014 RxList, Inc.
Serious - Use AlternativePossible serious or life-threatening interaction. Monitor closely. Use alternatives if available.

tipranavir oral and mefloquine oral

tipranavir oral increases levels of mefloquine oral by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use alternatives if available. Potential for increased toxicity. Avoid coadministration during and for 15 weeks after discontinuing mefloquine.

Clinical Drug Interactions Source: Medscape from WebMD
© 1994-2014 WebMD, LLC.

Check for more interactions with the Drug Interaction Checker

Drug Interaction Categories

Contraindicated

Never use this combination of drugs because of high risk for dangerous interaction

Serious

Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed

Significant

Potential for significant interaction (monitoring by your doctor is likely required)

Minor

Interaction is unlikely, minor, or nonsignificant

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for informational purposes only. This tool may not cover all possible drug interactions. Please check with a physician if you have health questions or concerns. Although we attempt to provide accurate and up-to-date information, no guarantee is made to that effect.

Women's Health

Find out what women really need.